• Publications
  • Influence
Three‐year results of a randomized clinical trial of lightweight or standard polypropylene mesh in Lichtenstein repair of primary inguinal hernia
This randomized trial examined whether lightweight (LW) polypropylene mesh (large pore size, partially absorbable) could have long‐term benefits in reducing chronic pain and inflammation afterExpand
Tacrolimus ointment does not affect collagen synthesis: results of a single-center randomized trial.
Findings suggest that tacrolimus does not cause skin atrophy and betamethasone was the only treatment to reduce skin thickness. Expand
Topical Noncorticosteroid Immunomodulation in the Treatment of Atopic Dermatitis
There is evidence from tacrolimus studies that monotherapy results in better long-term results when compared with combination therapy with corticosteroids, and topical noncorticosteroid compounds has not been associated with signs of immune deficiency. Expand
Early results of a single-blinded, randomized, controlled, Internet-based multicenter trial comparing Prolene and Vypro II mesh in Lichtenstein hernioplasty
Lichtenstein’s operation with either Prolene or Vypro II is safe and well tolerated with an acceptable postoperative rehabilitation time and a high quality of life 2 months after surgery. Expand
Comparison of cyclosporin and UVAB phototherapy for intermittent one-year treatment of atopic dermatitis.
It can be concluded that intermittent cyclosporin seems to be more effective than UVAB and is reasonably safe for the treatment of atopic dermatitis over a 1-year treatment period. Expand
Long-term follow-up of eczema patients treated with cyclosporine.
The study suggests that long-term remissions are possible in eczematous diseases treated with cyclosporine, even for a relatively short treatment period. Expand
A single accidental exposure may result in a chemical burn, primary sensitization and allergic contact dermatitis
Clinical cases in which a single exposure to concentrated antigen resulted in contact dermatitis suspected to be allergic were collected, and allergy to the allergens described must be considered strong allergens were revealed. Expand
Comparison of the influence of cyclosporine and topical betamethasone-17,21-dipropionate treatment on quality of life in chronic hand eczema.
Though the significant correlation between the total EDI and clinical assessments makes quality of life assessments in hand eczema questionable, the missing correlation between some clinical assessments and dimensions of the EDI suggests that EDI views aspects of the disease not covered by clinical measures. Expand
Comparison of cyclosporine and topical betamethasone-17,21-dipropionate in the treatment of severe chronic hand eczema.
Low-dose cyclosporine at 3 mg/kg/day is as effective as topical BDP in the treatment of chronic hand Eczema and could be useful as an alternative treatment for severe chronic hand eczema in patients unresponsive to conventional treatment. Expand
An economic evaluation of intermittent cyclosporin A therapy versus UVAB phototherapy in the treatment of patients with severe atopic dermatitis.
We performed a cost-effective evaluation of cyclosporin A versus UVAB phototherapy in the treatment of severe atopic dermatitis. The analysis was based on a one-year open prospective clinical trialExpand